BsmAb dose (mg/m2) | Group of patients | No. of patients | No. of anatomic sites | % of detected lesions |
---|---|---|---|---|
75 | All | 10 | 26 | 77% |
75 | Non-MTC | 4 | 9 | 100% |
75 | MTC | 6 | 17 | 65% |
40 | All | 9 | 23 | 62% |
40 | Non-MTC | 7 | 18 | 61% |
40 | MTC | 2 | 5 | 80% |
Calculations were made on an anatomic-site basis.